UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)-Reference-Cited by-同舟云学术

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

Published:2009-10 Issue:1 Volume:147 Page:22-42
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Bird Jenny,Behrens Judith,Westin Jan,Turesson Ingemar,Drayson Mark,Beetham Robert,D’Sa Shirley,Soutar Richard,Waage Anders,Gulbrandsen Nina,Gregersen Henrik,Low Eric,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07807.x/fullpdf

Reference70 articles.

1. Monoclonal gammopathy in lymphoma;Alexanian;Archives of Internal Medicine,1975

2. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients;Amara;Clinical Infectious Diseases,2006

3. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma;Avet-Loiseau;Cancer Research,1999

4. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population;Axelsson;Acta Medica Scandinavica,1966

5. Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins;Azar;The American Journal of Medicine,1957

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study;Scientific Reports;2024-02-28

2. Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients.;Haematologica;2023-10-19

3. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: update on laboratory tests for the study of monoclonal gammopathies;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-24

4. Medical practitioners’ knowledge and awareness of multiple myeloma at public hospitals, Gauteng, South Africa;South African Family Practice;2023-06-15

5. Quantitative Risk Factor Analysis of Prior Disease Condition and Socioeconomic Status with the Multiple Myeloma Development: Nationwide cohort study;2023-06-13